We investigated whether endothelial dysfunction might contribute to the exaggerated vasoconstriction that was induced by the administration of norepinephrine at the early stage of one-kidney, one-clip renal hypertension (1K1C) in rats. We also studied the role of the renin-angiotensin system in this phenomenon. Male Wistar rats were killed 48 hours after the induction of renal artery stenosis or sham operation, and ring preparations of the thoracic aorta were obtained. The isometric contraction and relaxation of aortic strips produced by norepinephrine and acetylcholine, respectively, were recorded with a force-displacement transducer. The aorta of 1K1C rats showed a significantly (P<.05) exaggerated contractile response to norepinephrine as compared with that of control rats. Rubbing the endothelium and treatment with methylene blue or N0-monomethyl L-arginine acetate augmented the contractile responses to norepinephrine to a greater extent in Although an increased vascular reactivity to vaso-L.1 constrictor substances has been observed both in clinical hypertension",2 and in animal models of hypertension,3-9 the mechanisms are not completely understood. Folkow et al10 suggest that this hyperresponsiveness in hypertension is due to vascular wall hypertrophy or medial hypertrophy that results in an increased vessel wall to lumen ratio. Findings of other investigators4,5"11 indicate that such mechanisms are not the only explanation. For instance, Prewitt et al"l reported that no vascular wall hypertrophy was observed in resistance vessels of one-kidney, one-clip renal hypertensive (iKiC) rats, despite a structural reduction in the size of the lumen. Others45 have reported that an exaggerated pressor response and increased sensitivity (change in threshold) to norepinephrine occur in rabbits with renal artery stenosis at an early stage, even before the onset of hypertension. These studies4,5"11 indicate that the exaggerated pressor response may be due to some alteration in the responsiveness of the vessels without hypertrophy of the vascular wall and suggest that the responsiveness of the vascular smooth muscle cells itself may be enhanced. However, confirmatory evidence is lacking.
We investigated whether endothelial dysfunction might contribute to the exaggerated vasoconstriction that was induced by the administration of norepinephrine at the early stage of one-kidney, one-clip renal hypertension (1K1C) in rats. We also studied the role of the renin-angiotensin system in this phenomenon. Male Wistar rats were killed 48 hours after the induction of renal artery stenosis or sham operation, and ring preparations of the thoracic aorta were obtained. The isometric contraction and relaxation of aortic strips produced by norepinephrine and acetylcholine, respectively, were recorded with a force-displacement transducer. The aorta of 1K1C rats showed a significantly (P<.05) exaggerated contractile response to norepinephrine as compared with that of control rats. Rubbing the endothelium and treatment with methylene blue or N0-monomethyl L-arginine acetate augmented the contractile responses to norepinephrine to a greater extent in
Although an increased vascular reactivity to vaso-L.1 constrictor substances has been observed both in clinical hypertension",2 and in animal models of hypertension,3-9 the mechanisms are not completely understood. Folkow et al10 suggest that this hyperresponsiveness in hypertension is due to vascular wall hypertrophy or medial hypertrophy that results in an increased vessel wall to lumen ratio. Findings of other investigators4,5"11 indicate that such mechanisms are not the only explanation. For instance, Prewitt et al"l re- ported that no vascular wall hypertrophy was observed in resistance vessels of one-kidney, one-clip renal hypertensive (iKiC) rats, despite a structural reduction in the size of the lumen. Others45 have reported that an exaggerated pressor response and increased sensitivity (change in threshold) to norepinephrine occur in rabbits with renal artery stenosis at an early stage, even before the onset of hypertension. These studies4, 5"11 indicate that the exaggerated pressor response may be due to some alteration in the responsiveness of the vessels without hypertrophy of the vascular wall and suggest that the responsiveness of the vascular smooth muscle cells itself may be enhanced. However, confirmatory evidence is lacking. Our objective was to determine the role of depressed synthesis and/or release of EDRF on the exaggerated vasoconstrictive response to norepinephrine at the early stage of hypertension before the development of vascular wall hypertrophy or an increased vascular wall to lumen ratio. The present study was designed to clarify the role of the renin-angiotensin system in endothelial dysfunction, using ACE inhibitors in 1KiC rats, because circulating angiotensin II is suggested to produce vascular and/or endothelial injury.29 '30 Two different ACE inhibitors, captopril and enalapril, were administered to evaluate the possibility that the sulfhydryl moiety of captopril would protect NO against the superoxidemediated breakdown. In addition, nicardipine as calcium antagonist was administered to determine the effect of a non-ACE inhibitor on the endothelial dysfunction in 1K1C rats.
Materials and Methods
Male Wistar rats that were 15 to 16 weeks old (Imai, Saitama, Japan) were used. They were individually caged, fed rat chow and water ad libitum, and maintained on a 12-hour light-dark cycle until the experiments were performed. Systolic blood pressure was measured by tail-cuff methods (model UR5000, Ueda Co, Tokyo, Japan). Rats were anesthetized with ethyl ether. After an incision was made in each flank, a silver clip 0.45 mm in diameter was placed on the right renal artery, and the left kidney was removed. Control rats were similarly treated, except that no clip was applied (shamoperated rats). In the preliminary study in seven rats, we observed that systolic blood pressure rose from 130±8 to 225 +45 mm Hg 4 weeks after the placement of a clip of this size. A prophylactic antibiotic (carumonam, 30 mg/kg IM) was injected after the surgery.
Forty-eight hours after the induction of renal artery stenosis or the sham operation, the rats were anesthetized with an intraperitoneal injection of pentobarbital (50 mg/kg) and then exsanguinated. The thorax was opened, and the descending thoracic aorta was immediately excised. The aorta was carefully removed to avoid damaging the endothelium. After removing the loose connective tissue, one or two cylindrical segments 3 mm long were cut from the aorta. The number of aortic rings obtained from each rat depended on the protocol (described below). Two stainless-steel wires (outer diameter, 0.1 mm) were inserted through the lumen of the aortic ring. One wire was anchored for stationary support, and the other was connected to a force-displacement transducer (model UR-50GR Minebea Co, Ltd, Nagano, Japan). The preparation was bathed in 10 mL Krebs' bicarbonate solution aerated with a mixture of 95% 02-5% CO2 and maintained at 37°C. (pH 7.4) . Agonists were applied to the bath in volumes of 0.1 mL using a calibrated pipette. The agonists were further diluted with the bath solution to achieve the final concentrations indicated in each protocol. The bath solution was continuously bubbled to obtain rapid mixing of the drug. To obtain a dose-response curve, the drug was added cumulatively from low to high concentrations. In a preliminary study, we tested addition of the drug from high to low concentrations, washing out the bath at each dosage, and obtained results similar to those seen with the cumulative application.
Rings were suspended under 2 g of tension. The force of isometric contraction was measured using a force-displacement transducer. Preparations were allowed to equilibrate for 90 minutes. In all cases, 100 ±L of norepinephrine mol/L) was initially applied to the bath to preconstrict the aortic strip. The concentration of norepinephrine in the final bath was 10-7 mol/L, as described above. After the contraction had reached a plateau at "2 minutes, the aorta was relaxed using 10-7 mol/L acetylcholine to confirm that the endothelium was intact. The bath solution was then washed out with Krebs In these experiments, we tested whether norepinephrineinduced vasoconstriction might be altered in 1K1C rats compared with sham-operated rats. The effects of three different kinds of treatment, ie, endothelial removal, soluble guanylate cyclase inhibition, and NO synthesis inhibition, were studied to evaluate the roles of endothelium, EDRF, and endotheliumderived NO on norepinephrine-induced vasoconstriction, respectively. Two aortic strips were excised from each rat. One strip was used to compare the response to norepinephrine between 1K1C and control rats and also served for the control experiments of another strip, which was used for the treatment of endothelial removal, guanylate cyclase inhibition with methylene blue, or NO synthesis inhibition with LNMMA.
Experiment JA: Role of endothelium on norepinephrine-induced vasoconstriction. Dose-related vasoconstriction to norepinephrine was studied in 1K1C and sham-operated rats with or without endothelium. Endothelium was removed in one of two aortic rings obtained from each rat by gently rubbing the intimal surface with a wooden stick.17 After the presence or absence of endothelium was confirmed by acetylcholine-induced vasodilation as described above, norepinephrine was added cumulatively to the bath to achieve the bath concentration from 10`1 to 10`6 mol/L. Then To determine the role of the renin-angiotensin system in endothelial dysfunction in 1K1C rats, an ACE inhibitor, captopril or enalapril, was administered orally to each group. We tested the effectiveness of ACE inhibition in a preliminary study. Three concentrations of captopril (0.01%, 0.05%, and 0.1%) or of enalapril (0.01%, 0.02%, and 0.05%) were given in the drinking water to normal Wistar rats (200 to 250 g body weight) for 3 days. The rats were anesthetized by an intraperitoneal injection of pentobarbital (50 mg/kg). The carotid artery and jugular vein were cannulated, and pressor responses to an intravenous infusion of angiotensin I (200 ng * kg`1 minw') and to angiotensin II (200 ng * kg`* min-') were observed. The increase in mean arterial pressure in response to intravenous angiotensin I was suppressed by the ACE inhibitors, being 33+±5, 26±8, and 6±3 mmHg after captopril was given at doses of 0.01%, 0.05%, and 0.1%, respectively. The response was 29±3, 20+6, and 12+4 mm Hg after enalapril was given at doses of 0.01%, 0.02%, and 0.05%, respectively. However, the increase in mean arterial pressure in response to angiotensin II was unaffected by the administration of ACE inhibitors, being 45±6, 59±1, and 39±9 mm Hg after captopril was given at doses of 0.01%, 0.05%, and 0.1% and 51+4, 42±7, and 43±4 mm Hg after enalapril was given at doses of 0.01%, 0.02%, and 0.05%, respectively. In the present study, we selected doses of 0.05% for captopril and 0.02% for enalapril to be given in the drinking water to inhibit ACE activity.
Experiment 24: Effect ofACE inhibition with captopril on the norepinephrine-induced vasoconstriction. Rats were divided into four groups: two groups of rats with renal artery stenosis and two sham-operated groups, with or without the oral administration of captopril. Two groups of rats were given 0.05% captopril in drinking water (z4150 mg . kg-'. d-1), and two groups received tap water. For each group, the protocol was begun 1 day before the induction of renal artery stenosis or the sham operation and continued for 48 hours after surgery. Renal artery stenosis and sham operation were performed as described in experiment 1. One aortic ring preparation was obtained from each rat, and the dose-response curve of the contractile responses to norepinephrine was determined as in experiment 1. Experiment 2B1: Effect ofACE inhibition with enalapril on the norepinephrine-induced vasoconstriction. Captopril has a sulfhydryl moiety in its structure, whereas enalapril does not. This moiety is reported to scavenge superoxide anion and protect EDRF breakdown.32,33 Therefore, we used enalapril in this experiment to inhibit ACE activity. The same protocol as in experiment 3A was performed using enalapril instead of captopril. Enalapril (,4100 mg-kg`. d-l) was given in the drinking water at a concentration of 0.02%. One aortic ring preparation was obtained from each rat, and the dose-response curve of contractile responses to norepinephrine was determined as in experiment 1.
Experiment 3: Alteration of EndotheliumDependent Relaxation Induced by Acetylcholine in 1K1C Rats Compared With Control Rats
Acetylcholine is an endothelium-dependent vasodilator. We determined whether there might be a difference in acetylcholine-induced vasodilation between 1K1C and control rats. The role of endothelium-derived NO in acetylcholine-induced vasodilation was also studied using LNMMA in both groups of rats. Two aortic strips were excised from each rat: one was used for the control study and the other was used after treatment with LNMMA. Aortic rings were incubated in Krebs' bicarbonate solution with or without LNMMA mol/L) for 30 minutes to equilibrate and then preconstricted by norepinephrine (10-7 mol/L). After the contraction had reached a plateau, 100 ,L acetylcholine was cumulatively applied to the bath to achieve final bath concentrations of 10t o 10-5 mol/L, and the relaxation responses were observed. We studied the effect of ACE inhibition with captopril on the vasodilation induced by acetylcholine. Captopril (0.05%) was administered in the drinking water as in experiment 2A. One aortic strip was excised from each rat. Aortic rings were incubated in Krebs' bicarbonate solution for 30 minutes to equilibrate and were then preconstricted by norepinephrine (10`mol/L). After the contraction had reached a plateau, 100 ,L acetylcholine was cumulatively applied to the bath to achieve final bath concentrations of 10`to To determine the effect of a non-ACE inhibitor on the endothelial dysfunction in 1K1C rats, nicardipine as the calcium antagonist was administered orally to each group. We tested the effect of oral administration of nicardipine on blood pressure in a preliminary study. Three concentrations of nicardipine (0.01%, 0.02%, and 0.06%) in the drinking water or tap water was given to control and 1K1C rats, 200 to 250 g body weight, beginning 1 day before the induction of renal artery stenosis or the sham operation and continuing for 48 hours after surgery. The systolic blood pressures of control rats (n=4 in each group), measured by tail-cuff methods, were 129+3, 128+2, 129+4, and 129+3 mm Hg 1 day before the sham operation and 130+5, 130+4, 126+2, and 123±2 mm Hg at the end of oral administration of tap water and of nicardipine at doses of 0.01%, 0.02%, and 0.06%, respectively. The systolic blood pressures of 1K1C rats (n=4 in each group) were 129+3, 130+6, 129+1, and 129±3 mmHg 1 day before the induction of renal artery stenosis and 136±2, 133±3, 133±4, and 133±3 mm Hg at the end of oral administration of tap water and of nicardipine at doses of 0.01%, 0.02%, and 0.06%, respectively.
In the present study, we selected doses of 0.02% nicardipine ("'30 mg. kg-1 . d-1) to be given in the drinking water. Rats were divided into four groups: two groups of rats with renal artery stenosis and two sham-operated groups, with or without the oral administration of nicardipine. Two groups of rats were given 0.02% nicardipine in the drinking water ('30 mg/kg), whereas two groups received tap water. For each group the protocol was begun 1 day before the induction of renal artery stenosis or the sham operation and continued for 48 hours after surgery. Renal artery stenosis and sham operation were performed as described in experiment 1. One aortic ring preparation was obtained from each rat, and the dose-response curve of the contractile response to norepinephrine was determined as in experiment 1.
Drug Application
Acetylcholine (Sigma Chemical Co, St Louis, Mo) and LNMMA (Calbiochem Co, La Jolla, Calif) were dissolved in saline, frozen, and stored at -20°C for no more than 6 weeks. Methylene blue (Sigmna) was prepared fresh daily in saline. Norepinephrine (noradrenaline) was a gift of Sankyo Pharmaceutical Co, Tokyo, Japan. These drugs were subsequently diluted with Krebs' bicarbonate solution to the desired concentrations and kept on ice in a dark container throughout the experiment. Captopril, enalapril, and nicardipine were dissolved daily in the drinking water. Captopril was kindly donated by Sankyo; enalapril, by Banyu Pharmaceutical Co; and nicardipine, by Yamanouchi Pharmaceutical Co, Tokyo, Japan.
Statistical Analysis
In each experimental group, n refers to the number of animals from which vessels were taken. Responses to norepinephrine or acetylcholine were expressed according to the method of Konishi and Su.14 In the vasoconstrictor response, the maximal response was considered to be the maximal force (in milligrams) of norepinephrine-induced vasoconstriction observed in the dose-response curve for each aortic preparation. The negative logarithm of the concentrations of norepinephrine that produced a half-maximal response was referred to as pD2. For the vasodilator response, the negative logarithm of the concentrations of acetylcholine that produced half the The isometric contraction of the aortic ring in response to norepinephrine was exaggerated in 1K1C rats as compared with control rats (Figs 1 through 4) . Both the pD2 and maximal constriction were significantly (P<.05) higher in 1K1C rats than in control rats (Tables 2, 3 , and 5). Removal of the endothelium produced a leftward shift in the norepinephrine-induced vasoconstriction and increased the pD2 and the maximal response in the control rats (Fig 1; Table 2 , experiment 1A). Removal of the endothelium abolished the difference in norepinephrine-induced vasoconstriction between control and 1K1C rats. After the treatment with methylene blue and LNMMA, pD2 and the maximal response increased significantly (P<.05) in both groups but were more pronounced in the control versus the 1K1C rats, and the difference in the vasoconstrictor response to norepinephrine between the two groups was diminished (Fig 2; Norepinephrine, -log (M) Norepinephrine, -log(M) Table 4 show the effect of oral administration of captopril on the acetylcholine-induced vasodilation in control and 1K1C rats. The relaxation was augmented by captopril in 1K1C rats, with a significant shift of the dose-response curves toward the left (Table  4) . In contrast to 1K1C rats, captopril did not change the dose-response curve in control rats (Table 4 ). There Table 5 show the effect of oral administration of nicardipine on the norepinephrine-induced vasoconstriction in control and 1K1C rats. pD2 and the maximal response were significantly (P<.01) higher in 1K1C than in control rats (Table 5) maximal response did not change significantly with nicardipine (Table 5) in control or 1K1C rats.
Discussion
The major findings of the present study are enhanced vasoconstriction to norepinephrine and depressed endothelium-dependent relaxations to acetylcholine in aortic rings at the early stage in 1K1C rats as compared with control rats. After the removal of endothelium and treatment with methylene blue and LNMMA, the difference in norepinephrine-induced vasoconstriction between 1K1C and control rats was diminished. LNMMA abolished the vasodilator response to acetylcholine in both the control and 1K1C rats. Oral administration of either captopril or enalapril normalized the vasoconstrictor response to norepinephrine to control levels in 1K1C rats. Captopril also restored acetylcholine-induced vasodilation in 1K1C rats. However, oral administration of a non-ACE inhibitor, the calcium antagonist EDRF is generated in the endothelium, is released to the vascular smooth muscle, and produces vasodilation.12"13" 5-17,26EDRF has recently been considered to be identical with NO and to be synthesized from L-arginine.19,20 Endothelium-derived NO has been demonstrated to be generated and/or released continuously, even without an exogenous endothelium-dependent vasodilator; the blockade of its synthesis using the L-arginine analogue LNMMA induces vasoconstriction in isolated blood vessels.20 '21 The basal release of endogenous NO could act as a functional antagonist to vasoconstrictors and may offer a protective role against hypertensive stimuli. In fact, the presence of the endothelium depresses the contraction evoked by norepinephrine. 2537 Conversely, a reduction of the release of endothelial NO could increase the vascular sensitivity to vasoconstrictive agents.
Interestingly, recent studies performed on isolated conduit arteries in vitro, primarily the aorta, have demonstrated that the release of EDRF stimulated by an endothelium-dependent vasodilator was reduced in several models of hypertension. '4-1626 In the present study, we also observed that acetylcholine-induced vasodilation, which was probably due to the reduced production of NO, was attenuated in 1K1C rats, since LNMMA treatment abolished the acetylcholineinduced vasodilation in both control and 1K1C rats. The present study demonstrated that norepinephrine-induced vasoconstriction, which was probably due to the reduced basal production of NO, was exaggerated in 1K1C rats, since the removal of the endothelium and the inhibition of soluble guanylate cyclase and NO synthase all enhanced the vasoconstriction more in control than in 1K1C rats. This evidence provides new insight into the mechanism of the enhanced vascular reactivity and pressor responsiveness to vasoconstrictive agents and could explain the role of reduction in EDRF in raising the vascular tone and blood pressure.
We studied agonist-induced vasoconstriction and vasodilation of the aortic ring preparation 48 produced during acute hypertension abolish the dilation of cerebral arterioles in response to acetylcholine. They have also shown that the vasodilatory response to acetylcholine is restored by the topical application of enzymatic inhibitors of oxygen radicals. Therefore, oxygen radicals, which could be generated in greater number in hypertension, may interfere with the action of NO or may damage the endothelium. The sulfhydryl moiety of captopril can scavenge superoxide anions; this ability presents a possible mechanism for the restoration of endothelial function in renal hypertension. However, we observed that endothelial dysfunction was improved by the treatment not only with captopril, which has a sulfhydryl moiety, but also with enalapril, which does not. Our results indicate that ACE inhibitors improve endothelial dysfunction, irrespectively of a sulfhydryl moiety. These observations suggest that the renin-angiotensin system may be more important than the superoxide anion in producing endothelial dysfunction at this stage in the 1K1C rat.
ACE inhibitors could also block kininase II and increase the level of bradykinin,41-4' an endotheliumdependent vasodilator. The vasodilation induced by bradykinin is mediated via NO and prostacyclin.124 An intact endothelium is required for the action of bradykinin. It has been reported that bradykinin-induced vasodilation is depressed in 1K1C rats. 45 Therefore, when endothelial function is normalized by the administration of an ACE inhibitor, the action of bradykinin in releasing endothelial vasodilators may also be restored, which could promote an antagonistic action of the endothelium against vasoconstrictive stimuli.
In conclusion, the aorta from 1K1C rats exhibited significantly exaggerated contractile responses to norepinephrine at the early stages of hypertension. Rubbing the endothelium and treatment with methylene blue or LNMMA augmented the contractile responses to norepinephrine to a greater extent in control than in 1K1C rats; therefore, the responses of the groups did not differ significantly. The relaxation response to acetylcholine was less in 1K1C than in control rats. The exaggerated contractile response of the aorta to norepinephrine in 1K1C rats was attenuated to the level found in control rats by treatment with captopril or enalapril. These results suggest that endothelial dysfunction may contribute to the exaggerated norepinephrine-induced vasoconstriction observed in the 1K1C rats and that angiotensin I-converting enzyme inhibitors can restore the endothelial function. The actions of sulfhydryl moiety in captopril to scavenge superoxide anions do not appear to be responsible for the restoration of the endothelial function, because enalapril also normalized the exaggerated vasoconstriction in this model of experimental hypertension.
